A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy

Ann Hematol. 2016 Jan;95(1):153-154. doi: 10.1007/s00277-015-2503-z. Epub 2015 Oct 7.

Authors

M Postorino¹, L Pupo², I Provenzano², M I Del Principe², F Buccisano², L Franceschini², M Rizzo², D Nasso², F Meconi², I Onnis², S Vaccarini², A Zizzari², L Anemona³, S Mauramati⁴, E Bruno⁴, M Cantonetti², S Amadori²

Affiliations

¹ Istituto di Ematologia, Dipartimento di Biomedicina e Prevenzione, Università Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. massimiliano.postorino@ptvonline.it.
² Istituto di Ematologia, Dipartimento di Biomedicina e Prevenzione, Università Tor Vergata, Viale Oxford 81, 00133, Rome, Italy.
³ Anatomia Patologica, Università Tor Vergata, Viale Oxford 81, 00133, Rome, Italy.
⁴ Dipartimento di Otorinolaringoiatria, Università Tor Vergata, Viale Oxford 81, 00133, Rome, Italy.

PMID: 26442854
DOI: 10.1007/s00277-015-2503-z

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Alemtuzumab
Antibodies, Monoclonal, Humanized / administration & dosage*
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Cyclophosphamide / administration & dosage
Doxorubicin / administration & dosage
Etoposide / administration & dosage
Humans
Male
Middle Aged
Mouth Neoplasms / diagnosis
Mouth Neoplasms / drug therapy*
Mycosis Fungoides / diagnosis
Mycosis Fungoides / drug therapy*
Prednisolone / administration & dosage
Skin Neoplasms / diagnosis
Skin Neoplasms / drug therapy*
Treatment Outcome
Vincristine / administration & dosage

Substances

Antibodies, Monoclonal, Humanized
Alemtuzumab
Vincristine
Etoposide
Doxorubicin
Cyclophosphamide
Prednisolone

Supplementary concepts

CHOEP protocol